Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Stintzing

Showing results (1-10 of 206) with videos related to

Pageof 21
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 28, 2017
[Personalized Treatment for Colorectal Carcinomas]Sebastian Stintzing
F1000Prime Reports|January 13, 2015
Management of colorectal cancerSebastian Stintzing
F1000Research|October 23, 2018
Recent advances in understanding colorectal cancerSebastian Stintzing
Cancer Discovery|June 4, 2015
Sym004: Truly a New Level of Anti-EGFR Treatment?Sebastian Stintzing, Volker Heinemann
Deutsche Medizinische Wochenschrift (1946)|November 6, 2021
[Neoadjuvant and adjuvant therapy of resectable colon cancer - Current standards and developments]Volker Heinemann, Sebastian Stintzing
Radiologie (Heidelberg, Germany)|April 23, 2025
[Molecular testing and liquid biopsies in colorectal cancer]Arndt Stahler, Sebastian Stintzing
Expert Opinion on Pharmacotherapy|August 15, 2013
Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!Sebastian Stintzing, Heinz-Josef Lenz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular pathways: turning proteasomal protein degradation into a unique treatment approachSebastian Stintzing, Heinz-Josef Lenz
Visceral Medicine|August 6, 2016
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future PerspectivesJulian Holch, Sebastian Stintzing, Volker Heinemann
The Lancet. Oncology|May 3, 2019
Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studiesDan Aderka, Sebastian Stintzing, Volker Heinemann
Pageof 21

Showing results (1-10 of 206) with videos related to

Sort By:
Pageof 21
Deutsche Medizinische Wochenschrift (1946)|October 28, 2017
[Personalized Treatment for Colorectal Carcinomas]Sebastian Stintzing
F1000Prime Reports|January 13, 2015
Management of colorectal cancerSebastian Stintzing
F1000Research|October 23, 2018
Recent advances in understanding colorectal cancerSebastian Stintzing
Cancer Discovery|June 4, 2015
Sym004: Truly a New Level of Anti-EGFR Treatment?Sebastian Stintzing, Volker Heinemann
Deutsche Medizinische Wochenschrift (1946)|November 6, 2021
[Neoadjuvant and adjuvant therapy of resectable colon cancer - Current standards and developments]Volker Heinemann, Sebastian Stintzing
Radiologie (Heidelberg, Germany)|April 23, 2025
[Molecular testing and liquid biopsies in colorectal cancer]Arndt Stahler, Sebastian Stintzing
Expert Opinion on Pharmacotherapy|August 15, 2013
Protein kinase inhibitors in metastatic colorectal cancer. Let's pick patients, tumors, and kinase inhibitors to piece the puzzle together!Sebastian Stintzing, Heinz-Josef Lenz
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 24, 2014
Molecular pathways: turning proteasomal protein degradation into a unique treatment approachSebastian Stintzing, Heinz-Josef Lenz
Visceral Medicine|August 6, 2016
Treatment of Metastatic Colorectal Cancer: Standard of Care and Future PerspectivesJulian Holch, Sebastian Stintzing, Volker Heinemann
The Lancet. Oncology|May 3, 2019
Explaining the unexplainable: discrepancies in results from the CALGB/SWOG 80405 and FIRE-3 studiesDan Aderka, Sebastian Stintzing, Volker Heinemann
Pageof 21